Primary Category:
Treatment Protocols
Disease Category:
Skin
Status:
Open
A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma
NCT#03712605
Eligible for screening study DCP 001
